Attached files

file filename
EX-31.2 - CFO 302 CERT - Endo International plcex31206302014cfo302cert.htm
EX-10.188 - JUL RRA-5.375-2023 - Endo International plcex10188julrra5375-2023.htm
EX-10.9.1 - APRIL 17 UNWIND AGREEMENT - Endo International plcex1091unwindagreementapril.htm
EX-10.9.2 - APRIL 21 UNWIND AGREEMENT - Endo International plcex1092unwindagreementapril.htm
EX-10.184 - MAY SUPP INDENT-7.00-2020 - Endo International plcex10184maysupind700-2020.htm
EX-10.191 - JUL SUPP INDENT-7.00-2019 - Endo International plcex10191julsupind700-2019.htm
EX-10.138 - ESPP - Endo International plcex10138amendedespp.htm
EX-10.194 - JUL RRA-7.25-2022 - Endo International plcex10194julrra725-2022.htm
EX-10.195 - JUL SUPP INDENT-7.25-2022 - Endo International plcex10195julsupind725-2022.htm
EX-10.192 - JUL RRA-7.00-2020 - Endo International plcex10192julrra700-2020.htm
EX-10.183 - MAY RRA 7.00-2020 - Endo International plcex10183mayrra700-2020.htm
EX-10.182 - MAY SUPP INDENT-7.00-2019 - Endo International plcex10182maysupind700-2019.htm
EX-10.190 - JUL RRA-7.00-2019 - Endo International plcex10190julrra700-2019.htm
EX-10.180 - MAY SUPP INDENT-575-2022 - Endo International plcex10180maysupind575-2022.htm
EX-21 - 06.30.2014 SUBSIDIARIES - Endo International plcex2106302014subsidiaries.htm
EX-32.2 - CFO 906 CERT - Endo International plcex32206302014cfo906cert.htm
EX-10.186 - MAY SUPP INDENT-7.25-2022 - Endo International plcex10186maysupind725-2022.htm
EX-32.1 - CEO 906 CERT - Endo International plcex32106302014ceo906cert.htm
EX-10.9.5 - JULY 21 UNWIND AGREEMENT-2 - Endo International plcex1095unwindagreementjuly2.htm
EX-10.189 - JUL SUPP INDENT-5.375-2023 - Endo International plcex10189julsupind5375-2023.htm
EX-10.185 - MAY RRA INDENT-7.25-2022 - Endo International plcex10185mayrra725-2022.htm
EX-10.187 - JUL SUPP INDENT-5.75-2022 - Endo International plcex10187julsupind575-2022.htm
EX-10.181 - MAY RRA-7.00-2019 - Endo International plcex10181mayrra700-2019.htm
EX-10.193 - JUL SUPP INDENT-7.00-2020 - Endo International plcex10193julsup700-2020.htm
EXCEL - IDEA: XBRL DOCUMENT - Endo International plcFinancial_Report.xls
10-Q - 10-Q - Endo International plcendp-06302014x10q.htm
EX-10.9.3 - APRIL 22 UNWIND AGREEMENT - Endo International plcex1093unwindagreementapril.htm
EX-10.9.4 - JULY 21 UNWIND AGREEMENT-1 - Endo International plcex1094unwindagreementjuly2.htm
Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
I, Rajiv De Silva, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Endo International plc;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s Board of Directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
/S/ RAJIV DE SILVA
Rajiv De Silva
President and Chief Executive Officer
(Principal Executive Officer)
 
 
Date:
August 4, 2014